Rescheduling on 25/02/2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Supha Pharmachem Ltd has postponed its Board Meeting originally scheduled for February 14, 2026 to February 25, 2026. The postponement is due to the non-availability of financial information from its overseas subsidiary in Singapore, which is needed to finalize consolidated financial results. The meeting will now consider and approve unaudited standalone and consolidated financial results for Q3 FY26 and the nine months ended December 31, 2025. The company's trading window for insiders remains closed since January 1, 2026 and will reopen 48 hours after the financial results are announced.
The 11-day delay is procedural and specific to waiting on Singapore subsidiary data for consolidated accounts. Standalone results could potentially be ready earlier. Shareholders should note the revised date of February 25, 2026 for the results announcement; no immediate effect on stock price is expected from the postponement itself.